Peptide Receptor Radionuclide Therapy (PRRT) with
177Lu-DOTATATE
PRRT
dosimetry
low-dose-radiation
pancreatic NEN
radionuclide therapy
small intestinal NEN
theranostics
vascularization
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 Feb 2021
25 Feb 2021
Historique:
received:
08
12
2020
revised:
12
01
2021
accepted:
19
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
7
3
2021
Statut:
epublish
Résumé
Dosimetry during peptide receptor radionuclide therapy (PRRT) has mainly focused on normal organs and less on the tumors. The absorbed dose in one target tumor per patient and several response related factors were assessed in 23 pancreatic neuroendocrine neoplasms (P-NENs) and 25 small-intestinal NEN (SI-NENs) during PRRT with
Identifiants
pubmed: 33668887
pii: cancers13050962
doi: 10.3390/cancers13050962
pmc: PMC7956792
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Eur J Endocrinol. 2010 Oct;163(4):691-7
pubmed: 20660557
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
J Nucl Med. 2013 Jan;54(1):33-41
pubmed: 23223392
Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):1025-36
pubmed: 10705026
Neuroendocrinology. 2020;110(7-8):662-670
pubmed: 31597134
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):212-25
pubmed: 19727718
Neuroendocrinology. 2011;93(3):189-96
pubmed: 21335949
J Nucl Med. 2014 Feb;55(2):183-90
pubmed: 24434296
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Endocr Relat Cancer. 2019 Jan 1;26(1):119-130
pubmed: 30400003
Gastroenterology. 2003 Oct;125(4):1094-104
pubmed: 14517793
Ann Oncol. 1999;10 Suppl 2:S23-9
pubmed: 10399029
Cancer. 2017 Dec 15;123(24):4770-4790
pubmed: 29112233
Cancer Cell. 2008 Mar;13(3):193-205
pubmed: 18328424
J Clin Oncol. 2008 May 1;26(13):2124-30
pubmed: 18445841
J Clin Oncol. 2011 Jun 10;29(17):2416-23
pubmed: 21555692
Expert Rev Mol Diagn. 2001 Sep;1(3):323-33
pubmed: 11901838
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2125-35
pubmed: 21892623
Clin Cancer Res. 2017 Aug 15;23(16):4617-4624
pubmed: 28428192
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1238-46
pubmed: 25808630
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):970-988
pubmed: 29497803
Acta Oncol. 2012 Jan;51(1):86-96
pubmed: 21961497
J Nucl Med. 2015 Feb;56(2):177-82
pubmed: 25593115
Semin Nucl Med. 2010 Mar;40(2):78-88
pubmed: 20113677
Endocr Rev. 2004 Jun;25(3):458-511
pubmed: 15180952
Front Oncol. 2020 Feb 21;10:193
pubmed: 32154181
Clin Cancer Res. 2007 Jan 1;13(1):187-96
pubmed: 17200354
Eur J Nucl Med Mol Imaging. 2014 May;41(5):925-33
pubmed: 24504504
Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):417-22
pubmed: 12634971
Radiat Res. 2005 Feb;163(2):216-21
pubmed: 15658898